Client Journeys
From seed-stage risk to Series A valuation
Representative journeys. We focus on the transformation, not just the grant win.
Representative journeys
DiagnosticAI
Healthtech
Challenge: Clinical validation pre-raise. Strategy: NIH Omnibus + NSF Phase I. Result: NIH Phase II $2.1M, $15M Series A.
“The NIH grant changed investor conversations.”
DefenseAI Systems
Dual-Use
Challenge: First customer, long sales cycles. Strategy: DoD SBIR via DSIP with Phase III plan. Result: $2.2M SBIR, $20M Phase III.
“They structured Phase I/II with transition in mind.”
GridPower
Cleantech
Challenge: Capital-intensive R&D. Strategy: NSF + IRAP + SR&ED. Result: $4.9M non-dilutive, $25M Series A.
“We raised from a position of strength.”
Ready to build your journey?
15-minute strategy call. We'll tell you if your technology is grant-fundable and which agencies are the best fit.
Book Strategy Review